By Patrick Wingrove (Reuters) -One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher ...

Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. Check ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $598.61 which represents a decrease of $-2.31 or -0.38% from the prior close of $600.92. The stock opened at $602.63 and ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 0.38% to $598.61 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5 ...

A Thermo Fisher 401(k) plan participant accused the company and its pension committee of violating ERISA by using forfeited ...

Shares of Thermo Fisher Scientific Inc. TMO rallied 3.26% to $619.33 Thursday, on what proved to be an all-around positive ...

Implementation of SAF for air shipments of clinical trial materials to meet Thermo Fisher's net-zero commitments.

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $612.94 which represents a decrease of $-5.63 or -0.91% from the prior close of $618.57. The stock opened at $620 and touched ...

Thermo Fisher Scientific Inc. today launched the Thermo Scientific™ iCAP™ MX Series ICP-MS to simplify trace element analysis ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas ...